Calidi Biotherapeutics, Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 4475 EXECUTIVE DRIVE, SAN DIEGO, CA, 92121
Mailing Address 4475 EXECUTIVE DRIVE, SAN DIEGO, CA, 92121
Phone 858-794-9600
Fiscal Year End 1231
EIN 862967193
Financial Overview
FY2024
-$22.14M
Net Income
$14.18M
Total Assets
$12.21M
Total Liabilities
$-2.97
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 10, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 10, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 4, 2026 | View on SEC |
| 8-K Current report of material events | January 29, 2026 | View on SEC |
| 4 Insider stock transaction report | December 16, 2025 | View on SEC |
| 8-K Current report of material events | November 13, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 13, 2025 | View on SEC |
| 8-K Current report of material events | November 10, 2025 | View on SEC |
| 8-K Current report of material events | October 31, 2025 | View on SEC |
| 8-K Current report of material events | October 24, 2025 | View on SEC |
Insider Trading
SELL 1 insiders
1 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.